These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J7185

  Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.

• J7186

  Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.

• J7187

  Injection, von willebrand factor complex (humate-p), per iu vwf:rco

• J7188

  Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.

• J7189

  Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram

• J7190

  Factor viii (antihemophilic factor, human) per i.u.

• J7191

  Factor viii (antihemophilic factor (porcine)), per i.u.

• J7192

  Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified

• J7193

  Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.

• J7194

  Factor ix, complex, per i.u.

• J7195

  Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified

• J7196

  Injection, antithrombin recombinant, 50 i.u.

• J7197

  Antithrombin iii (human), per i.u.

• J7198

  Anti-inhibitor, per i.u.

• J7199

  Hemophilia clotting factor, not otherwise classified

• J7200

  Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu

• J7201

  Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.

• J7202

  Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.

• J7203

  Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu

• J7204

  Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu

• J7205

  Injection, factor viii fc fusion protein (recombinant), per iu

• J7207

  Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.

• J7208

  Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.

• J7209

  Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.

• J7210

  Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.

• J7211

  Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.

• J7212

  Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram

• J7213

  Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.

• J7214

  Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.

• J7294

  Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each

• J7295

  Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each

• J7296

  Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg

• J7297

  Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg

• J7298

  Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg

• J7299

  Intrauterine copper contraceptive (miudella)

• J7300

  Intrauterine copper contraceptive (paragard)

• J7301

  Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg

• J7302

  Levonorgestrel-releasing intrauterine contraceptive system, 52 mg

• J7303

  Contraceptive supply, hormone containing vaginal ring, each

• J7304

  Contraceptive supply, hormone containing patch, each

• J7306

  Levonorgestrel (contraceptive) implant system, including implants and supplies

• J7307

  Etonogestrel (contraceptive) implant system, including implant and supplies

• J7308

  Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)

• J7309

  Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram

• J7310

  Ganciclovir, 4.5 mg, long-acting implant

• J7311

  Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg

• J7312

  Injection, dexamethasone, intravitreal implant, 0.1 mg

• J7313

  Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg

• J7314

  Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg

• J7315

  Mitomycin, ophthalmic, 0.2 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.